Nod for Paxlovid's Indian generic version to take longer

Hetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. However, their proposal was turned down.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/v79hdps
via IFTTT